Circulating Sulfhydryl Oxidase and Risk of Cardiovascular Disease

被引：0
|
作者：
Qian, Juying
Chen, Ao
Chen, Zhangwei
Ge, Junbo
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Biomarkers; Cardiovascular disease; Biomedical informatics;
D O I：
10.1161/circ.148.suppl_1.14734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14734
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
    Wong, Yuen-Kwun
    Tse, Hung-Fat
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [2] Circulating Markers of Liver Function and Cardiovascular Disease Risk
    Targher, Giovanni
    Byrne, Christopher D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (11) : 2290 - 2296
  • [3] Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk
    Feaver, Ryan E.
    Bowers, M. Scott
    Cole, Banumathi K.
    Hoang, Steve
    Lawson, Mark J.
    Taylor, Justin
    LaMoreaux, Brian D.
    Zhao, Lin
    Henke, Brad R.
    Johns, Brian A.
    Nyborg, Andrew C.
    Wamhoff, Brian R.
    Figler, Robert A.
    PLOS ONE, 2023, 18 (09):
  • [4] Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
    Hirotaka Saito
    Kenichi Tanaka
    Tsuyoshi Iwasaki
    Akira Oda
    Shuhei Watanabe
    Makoto Kanno
    Hiroshi Kimura
    Michio Shimabukuro
    Koichi Asahi
    Tsuyoshi Watanabe
    Junichiro James Kazama
    Scientific Reports, 11
  • [5] Risk Of Cardiovascular Disease and Use Of Xanthine Oxidase Inhibitors For Gout
    Kim, Seoyoung C.
    Schneeweiss, Sebastian
    Choudhry, Niteesh
    Liu, Jun
    Glynn, Robert J.
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S729 - S729
  • [6] Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
    Saito, Hirotaka
    Tanaka, Kenichi
    Iwasaki, Tsuyoshi
    Oda, Akira
    Watanabe, Shuhei
    Kanno, Makoto
    Kimura, Hiroshi
    Shimabukuro, Michio
    Asahi, Koichi
    Watanabe, Tsuyoshi
    Kazama, Junichiro James
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
    Haybar, Habib
    Shokuhian, Mohammad
    Bagheri, Marziye
    Davari, Nader
    Saki, Najmaldin
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 132 : 110 - 119
  • [8] CIRCULATING CARDIOVASCULAR DISEASE RISK FACTORS AND SIGNALING IN ENDOTHELIAL CAVEOLAE
    Shaul, Philip
    Mineo, Chieko
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S2 - S2
  • [9] Obstructive sleep apnea, circulating microRNAs, and risk of cardiovascular disease
    Lisan, Q.
    Marques-Vidal, P.
    Hausler, N.
    Danchin, N.
    Boutouyrie, P.
    Asselin, A.
    Jouven, X.
    Heinzer, R.
    Empana, J. P.
    SLEEP MEDICINE, 2023, 109 : 1 - 3
  • [10] Circulating Proangiogenic Cell Activity Is Associated with Cardiovascular Disease Risk
    Mavromatis, Kreton
    Aznaouridis, Konstantinos
    Al Mheid, Ibhar
    Veledar, Emir
    Dhawan, Saurabh
    Murrow, Jonathan R.
    Forghani, Zohreh
    Sutcliffe, Diane J.
    Ghasemzadeh, Nima
    Alexander, R. Wayne
    Taylor, W. Robert
    Quyyumi, Arshed A.
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (09) : 1163 - 1170
12345